Skip to main content
. Author manuscript; available in PMC: 2009 May 1.
Published in final edited form as: Gastroenterology. 2008 Jan 30;134(5):1369–1375. doi: 10.1053/j.gastro.2008.01.07

Table 3.

Substrate kinetics during basal conditions and during stage 1 (low-dose insulin) and stage 2 (high-dose insulin) of the hyperinsulinemic-euglycemic clamp procedure in the entire cohort of study subjects.

Basal Stage 1 Stage 2
Endogenous Glucose Ra (μmol·kg FFM−1 · min−1) 14.0 ± 1.8 4.2 ± 1.7 1.6 ± 1.9
Glucose Rd (μmol·· kg FFM−1·· min−1) 14.4 ± 1.8 21.0 ± 7.3 46.7 ± 16.1
Palmitate Ra) (μmol·· kg FFM−1·· min−1) 2.1 ± 0.6 0.7 ± 0.3 0.4 ± 0.2

Values are means±SD

Ra=rate of appearance